Cargando…

Alleviating toxic α-Synuclein accumulation by membrane depolarization: evidence from an in vitro model of Parkinson’s disease

Parkinson’s disease (PD) is characterized by the formation of toxic, fibrillar form alpha-synuclein (α-Syn) protein aggregates in dopaminergic neurons. Accumulating evidence has shown a multifactorial interplay between the intracellular calcium elevation and α-Syn dynamics. However, whether membrane...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ross, Alysia, Xing, Viktoria, Wang, Ting Ting, Bureau, Samantha C., Link, Giovana A., Fortin, Teresa, Zhang, Hui, Hayley, Shawn, Sun, Hongyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395353/ https://www.ncbi.nlm.nih.gov/pubmed/32736645 http://dx.doi.org/10.1186/s13041-020-00648-8

Ejemplares similares

Developmentally Regulated Rebound Depolarization Enhances Spike Timing Precision in Auditory Midbrain Neurons
por: Sun, Hongyu, et al.
Publicado: (2020)

Alpha-synuclein Toxicity in the Early Secretory Pathway: How It Drives Neurodegeneration in Parkinsons Disease
por: Wang, Ting, et al.
Publicado: (2015)

Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
por: Dening, Yanina, et al.
Publicado: (2022)

Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease
por: Davies, Sian E., et al.
Publicado: (2014)

TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tau
por: Rousseaux, Maxime WC, et al.
Publicado: (2016)

Loss of Functional Alpha-Synuclein: A Toxic Event in Parkinson’s Disease?
por: Kanaan, Nicholas M., et al.
Publicado: (2012)

Small soluble α-synuclein aggregates are the toxic species in Parkinson’s disease
por: Emin, Derya, et al.
Publicado: (2022)

Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
por: García-Revilla, Juan, et al.
Publicado: (2023)

Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease
por: Gou, De-Hai, et al.
Publicado: (2020)

Targeted attenuation of elevated histone marks at SNCA alleviates α‐synuclein in Parkinson's disease
por: Guhathakurta, Subhrangshu, et al.
Publicado: (2021)

Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson’s Disease Models In Vivo and In Vitro
por: Hsu, Yu-Ling, et al.
Publicado: (2021)

The mechanism of sirtuin 2–mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease
por: de Oliveira, Rita Machado, et al.
Publicado: (2017)

TOM40 Mediates Mitochondrial Dysfunction Induced by α-Synuclein Accumulation in Parkinson’s Disease
por: Bender, Andreas, et al.
Publicado: (2013)

Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson’s disease
por: Kim, Changyoun, et al.
Publicado: (2015)

Parkinson’s disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein
por: Araki, Katsuya, et al.
Publicado: (2019)

GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
por: Schneider, Jay S., et al.
Publicado: (2019)

Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease
por: Mori, Akio, et al.
Publicado: (2020)

Melatonin Alleviates Antimony Toxicity by Regulating the Antioxidant Response and Reducing Antimony Accumulation in Oryza sativa L.
por: Chu, Yutan, et al.
Publicado: (2023)

Correction: The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease
por: de Oliveira, Rita Machado, et al.
Publicado: (2017)

Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys
por: Alarcón-Arís, Diana, et al.
Publicado: (2020)

Parkinson’s disease risk genes act in glia to control neuronal α-synuclein toxicity
por: Olsen, Abby L, et al.
Publicado: (2021)

α-Synuclein Toxicity in Drosophila melanogaster Is Enhanced by the Presence of Iron: Implications for Parkinson’s Disease
por: Agostini, Francesco, et al.
Publicado: (2023)

Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model
por: Chatterjee, Diptaman, et al.
Publicado: (2018)

MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease
por: Geng, Lu, et al.
Publicado: (2023)

Age-dependent alpha-synuclein accumulation and aggregation in the colon of a transgenic mouse model of Parkinson’s disease
por: Chen, Qian-Qian, et al.
Publicado: (2018)

Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease
por: Reyes, Juan F., et al.
Publicado: (2021)

DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease
por: Zondler, L, et al.
Publicado: (2014)

Heparan sulfate proteoglycans mediate prion-like α-synuclein toxicity in Parkinson’s in vivo models
por: Chen, Merry, et al.
Publicado: (2022)

Phosphorylation of α-synuclein at T64 results in distinct oligomers and exerts toxicity in models of Parkinson’s disease
por: Matsui, Hideaki, et al.
Publicado: (2023)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

Effects of pramipexole treatment on the α-synuclein content in serum exosomes of Parkinson's disease patients
por: Luo, He-Ting, et al.
Publicado: (2016)

α-Synuclein induced cholesterol lowering increases tonic and reduces depolarization-evoked synaptic vesicle recycling and glutamate release
por: Lazarevic, Vesna, et al.
Publicado: (2022)

A novel yeast‐based screening system for potential compounds that can alleviate human α‐synuclein toxicity
por: Sangkaew, Anyaporn, et al.
Publicado: (2021)

Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson’s Disease Patient-Specific Dopamine Neurons
por: Ferrer-Lorente, Raquel, et al.
Publicado: (2021)

ATP13A2 Declines Zinc-Induced Accumulation of α-Synuclein in a Parkinson’s Disease Model
por: Gao, Huiling, et al.
Publicado: (2022)

IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson’s disease models
por: Arcos, Javiera, et al.
Publicado: (2023)

Depolarization of electrons
por: Robinson, K W
Publicado: (1967)

Transmission of alpha-synuclein in Parkinson’s disease
por: Lee, Virginia M-Y
Publicado: (2013)

Alpha-synuclein spreading in Parkinson’s disease
por: Recasens, Ariadna, et al.
Publicado: (2014)

Alpha-Synuclein Aggregation in Parkinson's Disease
por: Srinivasan, E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kq9vajc3t6l753l45vmv4k0ehh